Lightcalls.com
 

Anyone who has survived a Minnesota...

Anyone who has survived a Minnesota winter or backed on the outside of a sticky situation at the last minute knows what it's like to have frigid feet. For people with Raynaud's phenomenon, however, having arctic feet -- or fingers, ears or noses -- can be a serious health problem

Raynaud's phenomenon is a disorder in which vital fluid vessels (typically in fingers and toes) constrict during episodic attacks, limiting kindred flow and warmth to these areas. in all senses to cold and emotional stres are the usual triggers for the disorder, which is greatest in number common in women between 15 and 50 years of age.

The human carcass moves arterial blood from the surface to the body's core in order to preserve the vital organs working when expos to frigid There is nothing unusual about this. moreover in those with Raynaud's phenomenon, this replication is exaggerated; the small vital current vessels, or arterioles, that carry descendants to fingers and toes, abruptly contract in spasms, dramatically lowering life-current supply (and, thereby, oxygen supply) to the extremities. This can cause collapsed arteries, skin discoloration -- usually white, then melancholy then red as blood turn backs -- as well as throbbing and tingling at the close of attacks, lasting anywhere from les than a minute to several hours.

Raynaud's disease v Raynaud's phenomenon



It's important to distinguish between primary and secondary forms of Raynaud's disorder. Primary Raynaud's phenomenon is frequently called Raynaud's disease, and the cause of it is unknown. It is the mildest and in the greatest degree common form, and the majority of nation with this form of Raynaud's don't experience a secondary disease as a result

by conversion secondary Raynaud's phenomenon can be caused by dint of related health problems, such as carpal underground thoroughfare syndrome, lupus, scleroderma and mixed connective tissue disease, in which children vessel walls thicken and constrict too frequently limiting blood flow. People who work with vibrating tools and those who impressed sign or play piano are also susceptible. smooth drugs including beta-blockers prescribed for high line pressure, chemotherapy agents and a certain number of narcotics and over-the-counter cold medications have been linked to the secondary form. The greatest in quantity serious problems resulting from the secondary form are skin sore s and, in severe cases, gangrene in toes and fingers.

Raynaud's relief

Now for the worthy news: Many patients with Raynaud's phenomenon find relief from symptoms and feel no additional complications. Conventional treatment, especially of the secondary form, frequently includes prescription drugs, but these can cause side consequences including ankle swelling, headache, flushing, weight gain, acne and irregular heartbeat. Lifestyle changes and natural continuations that encourage better circulation, upon the other hand, are effective alternatives for an sufferers. Here are a hardly any supplements that have shown promise in alleviating Raynaud's:

* Ginkgo

A growing dead body of research shows that Ginkgo biloba increases line flow when taken orally on those with impaired circulation in extremities, leading scientists to believe that ginkgo supplementation may be useful in treating Raynaud's disease. In his work The Green Pharmacy, noted herbalist James A. Duke PhD moves a standardized extract of 60-240 mg by day of ginkgo.

* Essential fatty acids (EFAs)

fresh research suggests that supplementation with omega-3 and omega-6 essential fatty acids (EFAs) may be useful because they decrease platelet aggregation, which can limit children flow. Flaxseed oil contains the two omega-3 and omega-6 EFAs. individual gram of evening primrose oil (EPO) by day, which contains gamma-linolenic acid, may also be beneficial. a certain quantity of natural practitioners recommend massaging the oil into affected fingers and toes to improve kin flow, as well. Hemp se oil and oils lay the foundation of in nuts, seeds and fish are other religious sources of EFAs.

* Niacin

Many practitioners commend niacin, including Andrew Weil, MD in his volume Natural Health, Natural Medicine. Niacin induces relations vessel dilation that results in warm flushing and tingling in the skin's surface. Weil insinuates taking 100 mg twice a day with bread Ask for flush-free niacin.

more [i]or[/i] less practitioners also recommend taking garlic (which, like EFAs, decreases platelet aggregation), cayenne, ginger, vitamin E and Indian snakeroot, which increase peripheral vasodilation. Ginger, mustard and cayenne might also help when massaged into the skin. These are examples of rubefacients, meaning they increase life-current supply to the area by means of causing minor irritation. To make a mustard plaster, Duke hints mixing warm water and four ounce of renewed ground mustard seed and applying it during attacks.

Duke presents the following tasty recipe to help sufferer of Raynaud's warm up: "On a shivering day," he explains, "I'd have fruition of a vegetarian bouillon containing profitable gamma-linolenic (GLA) sources (oils of borage, currant and evening primrose), spiced up with cayenne, garlic, ginger, horseradish, mustard and turmeric." In addition to sipping the broth he recommends using it as a rubefacient massage. Apparently, praying with your aliment can actually be good for you.



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.